Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Trisalus Life Sciences Entered A $50M, Five-year Credit Agreement With Orbimed, Securing $25M Upfront. An Additional $10M Is Available Until June 30, 2025, And $15M Until December 31, 2025, Contingent On Revenue Targets

Author: Benzinga Newsdesk | February 19, 2025 07:19am

Posted In: TLSI